{"id":"https://openalex.org/W2064520145","doi":"https://doi.org/10.1177/0091270010368678","title":"Effect of Antipsychotic Medications on Glucose and Lipid Levels","display_name":"Effect of Antipsychotic Medications on Glucose and Lipid Levels","publication_year":2010,"publication_date":"2010-04-22","ids":{"openalex":"https://openalex.org/W2064520145","doi":"https://doi.org/10.1177/0091270010368678","mag":"2064520145","pmid":"https://pubmed.ncbi.nlm.nih.gov/20410451"},"language":"en","primary_location":{"id":"doi:10.1177/0091270010368678","doi":"https://doi.org/10.1177/0091270010368678","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0091270010368678","pdf_url":null,"source":{"id":"https://openalex.org/S146237847","display_name":"The Journal of Clinical Pharmacology","issn_l":"0021-9754","issn":["0021-9754","0091-2700","0095-9863","1552-4604","2375-0839","2375-0928"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Pharmacology","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021436800","display_name":"Parminder S Chaggar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210113642","display_name":"Essex Cardiothoracic Centre","ror":"https://ror.org/024zgsn52","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I263303288","https://openalex.org/I4210113642"]},{"id":"https://openalex.org/I4210127968","display_name":"Basildon Hospital","ror":"https://ror.org/02de7mm40","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I263303288","https://openalex.org/I4210127968"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Parminder S. Chaggar","raw_affiliation_strings":["Essex Cardiothoracic Centre, Basildon Hospital, Nethermayne, Basildon, SS16 5NL UK. pchaggar@doctors.org.uk","Essex Cardiothoracic Centre, Basildon Hospital, Basildon, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Essex Cardiothoracic Centre, Basildon Hospital, Nethermayne, Basildon, SS16 5NL UK. pchaggar@doctors.org.uk","institution_ids":["https://openalex.org/I4210113642","https://openalex.org/I4210127968"]},{"raw_affiliation_string":"Essex Cardiothoracic Centre, Basildon Hospital, Basildon, United Kingdom","institution_ids":["https://openalex.org/I4210113642","https://openalex.org/I4210127968"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027485567","display_name":"Steven M. Shaw","orcid":"https://orcid.org/0000-0002-4939-3728","observed_orcids":["https://orcid.org/0000-0002-4939-3728"]},"institutions":[{"id":"https://openalex.org/I4210150798","display_name":"Wythenshawe Hospital","ror":"https://ror.org/05vpsdj37","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210092852","https://openalex.org/I4210150798"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Steven M. Shaw","raw_affiliation_strings":["Northwest Heart and Transplant Centre, Wythenshawe Hospital, Manchester, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Northwest Heart and Transplant Centre, Wythenshawe Hospital, Manchester, United Kingdom","institution_ids":["https://openalex.org/I4210150798"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5006647774","display_name":"Simon G. Williams","orcid":"https://orcid.org/0000-0001-7396-4108","observed_orcids":["https://orcid.org/0000-0001-7396-4108"]},"institutions":[{"id":"https://openalex.org/I4210150798","display_name":"Wythenshawe Hospital","ror":"https://ror.org/05vpsdj37","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I4210092852","https://openalex.org/I4210150798"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Simon G. Williams","raw_affiliation_strings":["Northwest Heart and Transplant Centre, Wythenshawe Hospital, Manchester, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Northwest Heart and Transplant Centre, Wythenshawe Hospital, Manchester, United Kingdom","institution_ids":["https://openalex.org/I4210150798"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4150,"currency":"USD","value_usd":4150},"apc_paid":null,"fwci":0.7898,"has_fulltext":false,"cited_by_count":66,"citation_normalized_percentile":{"value":0.57813998,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"51","issue":"5","first_page":"631","last_page":"638"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.8769999742507935},{"id":"https://openalex.org/keywords/metabolic-side-effects","display_name":"metabolic side effects","score":0.6919999718666077},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.8019999861717224},{"id":"https://openalex.org/keywords/dyslipidemia","display_name":"dyslipidemia","score":0.9980000257492065},{"id":"https://openalex.org/keywords/glucose-metabolism","display_name":"glucose metabolism","score":0.5440000295639038},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.8759999871253967},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.7250000238418579},{"id":"https://openalex.org/keywords/bipolar-disorder","display_name":"bipolar disorder","score":0.9340000152587891},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.9290000200271606},{"id":"https://openalex.org/keywords/olanzapine","display_name":"olanzapine","score":0.9300000071525574},{"id":"https://openalex.org/keywords/clozapine","display_name":"clozapine","score":1.0},{"id":"https://openalex.org/keywords/ziprasidone","display_name":"ziprasidone","score":0.9890000224113464},{"id":"https://openalex.org/keywords/atherogenic-risk","display_name":"atherogenic risk","score":0.5540000200271606}],"concepts":[{"id":"https://openalex.org/C2777270317","wikidata":"https://www.wikidata.org/wiki/Q205517","display_name":"Ziprasidone","level":4,"score":0.8841503262519836},{"id":"https://openalex.org/C2776619155","wikidata":"https://www.wikidata.org/wiki/Q201872","display_name":"Olanzapine","level":3,"score":0.8289258480072021},{"id":"https://openalex.org/C2778096610","wikidata":"https://www.wikidata.org/wiki/Q1476525","display_name":"Dyslipidemia","level":3,"score":0.8011922240257263},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.7814439535140991},{"id":"https://openalex.org/C2780864610","wikidata":"https://www.wikidata.org/wiki/Q221361","display_name":"Clozapine","level":3,"score":0.7440948486328125},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7431190013885498},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.6635298728942871},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.5632641911506653},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5061101317405701},{"id":"https://openalex.org/C2776921671","wikidata":"https://www.wikidata.org/wiki/Q758295","display_name":"Atypical antipsychotic","level":4,"score":0.49802350997924805},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47096875309944153},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4539778232574463},{"id":"https://openalex.org/C2776174506","wikidata":"https://www.wikidata.org/wiki/Q131755","display_name":"Bipolar disorder","level":3,"score":0.4188781976699829},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.2581920623779297},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.21854639053344727},{"id":"https://openalex.org/C2780733359","wikidata":"https://www.wikidata.org/wiki/Q331769","display_name":"Mood","level":2,"score":0.04918193817138672}],"mesh":[{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007333","descriptor_name":"Insulin Resistance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008055","descriptor_name":"Lipids","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D018570","descriptor_name":"Risk Assessment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019317","descriptor_name":"Evidence-Based Medicine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D044882","descriptor_name":"Glucose Metabolism Disorders","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D044882","descriptor_name":"Glucose Metabolism Disorders","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D044882","descriptor_name":"Glucose Metabolism Disorders","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D050171","descriptor_name":"Dyslipidemias","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D050171","descriptor_name":"Dyslipidemias","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1177/0091270010368678","doi":"https://doi.org/10.1177/0091270010368678","is_oa":false,"landing_page_url":"https://doi.org/10.1177/0091270010368678","pdf_url":null,"source":{"id":"https://openalex.org/S146237847","display_name":"The Journal of Clinical Pharmacology","issn_l":"0021-9754","issn":["0021-9754","0091-2700","0095-9863","1552-4604","2375-0839","2375-0928"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmid:20410451","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20410451","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical pharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/8a7989dc-e733-41a7-8ace-1b319b4e0e7e","doi":null,"is_oa":false,"landing_page_url":"https://research.manchester.ac.uk/en/publications/8a7989dc-e733-41a7-8ace-1b319b4e0e7e","pdf_url":null,"source":{"id":"https://openalex.org/S4306400662","display_name":"Research Explorer (The University of Manchester)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I28407311","host_organization_name":"University of Manchester","host_organization_lineage":["https://openalex.org/I28407311"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chaggar, P S, Shaw, S M & Williams, S G 2011, 'Effect of antipsychotic medications on glucose and lipid levels', Journal of Clinical Pharmacology, vol. 51, no. 5, pp. 631-638. https://doi.org/10.1177/0091270010368678","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W21713058","https://openalex.org/W1493671385","https://openalex.org/W1727437553","https://openalex.org/W1970358906","https://openalex.org/W1971131166","https://openalex.org/W1976706794","https://openalex.org/W1990084913","https://openalex.org/W1994539827","https://openalex.org/W1994877202","https://openalex.org/W2002056000","https://openalex.org/W2031713362","https://openalex.org/W2049994834","https://openalex.org/W2056675454","https://openalex.org/W2062113087","https://openalex.org/W2073310236","https://openalex.org/W2076607047","https://openalex.org/W2083168772","https://openalex.org/W2083311377","https://openalex.org/W2084278623","https://openalex.org/W2084561734","https://openalex.org/W2090658963","https://openalex.org/W2105918612","https://openalex.org/W2112728783","https://openalex.org/W2112815097","https://openalex.org/W2112972934","https://openalex.org/W2114637662","https://openalex.org/W2143578692","https://openalex.org/W2146713994","https://openalex.org/W2151838682","https://openalex.org/W2152723116","https://openalex.org/W2159155203","https://openalex.org/W4232676895"],"related_works":["https://openalex.org/W113842342","https://openalex.org/W2121790486","https://openalex.org/W2151838682","https://openalex.org/W2086497164","https://openalex.org/W6892582828","https://openalex.org/W4312395432","https://openalex.org/W1990045961","https://openalex.org/W2027071417","https://openalex.org/W7168375637","https://openalex.org/W2970747107"],"abstract_inverted_index":{"Severe":[0],"mental":[1],"illnesses,":[2],"such":[3],"as":[4],"schizophrenia":[5],"and":[6,16,45,50,60,63,94],"bipolar":[7],"affective":[8],"disorder,":[9],"are":[10,37,92],"associated":[11,38,67],"with":[12,39,68],"excess":[13],"cardiovascular":[14],"morbidity":[15],"mortality.":[17],"Cardiovascular":[18],"risk":[19],"in":[20],"psychiatric":[21],"disorders":[22],"is":[23,98],"partly":[24],"related":[25],"to":[26,56,79],"antipsychotic":[27,35],"therapy,":[28],"especially":[29],"second-generation":[30],"or":[31],"atypical":[32],"antipsychotics.":[33],"Some":[34],"medications":[36],"proatherogenic":[40],"conditions":[41],"including":[42],"insulin":[43,58],"resistance":[44,59],"dyslipidemia.":[46,61],"In":[47],"particular,":[48],"olanzapine":[49],"clozapine":[51],"have":[52],"been":[53],"consistently":[54],"demonstrated":[55],"promote":[57],"Ziprasidone":[62],"amisulpiride":[64],"may":[65],"be":[66],"more":[69],"favorable":[70],"metabolic":[71,80],"effects.":[72],"Many":[73],"of":[74,82],"the":[75,95],"published":[76],"data":[77,91],"relating":[78],"effects":[81],"anti-psychotics":[83],"originate":[84],"from":[85],"retrospective":[86],"studies.":[87],"However,":[88],"prospective":[89],"randomized-controlled":[90],"emerging,":[93],"latest":[96],"evidence":[97],"described":[99],"here.":[100]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":6},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}